Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Cell Surface Markers Companies

Cell surface markers, also known as cell surface antigens or cell surface proteins, are molecules located on the surface of cells that can be used to identify and characterize different cell types. Various companies specialize in the development and production of antibodies, kits, and reagents for the detection and analysis of cell surface markers.

Cell Surface Markers Key Companies Latest Cell Surface Markers Companies Update

July 2023: A prospective FDA-reviewed lower-cost alternative to an ex vivo SCD therapy has prompted Sanofi and Scribe Therapeutics to form a collaboration with a maximum value of over $1.2 billion in order to develop an in vivo genome editing therapy for the genetic disorder. The organizations formed a partnership with the potential to invest up to $1 billion in CRISPR-based cell therapies for cancer research last year. This collaboration has advanced; inquiries regarding particulars are being directed to Sanofi. Scribe and Sanofi intend to extend their most recent collaboration to the development of therapies for additional genomic diseases should they both achieve success in SCD. However, the number of such diseases is not specified by the companies. Scribe utilizes genetic modification platforms to construct and implement its array of CRISPR technologies in the treatment of hematopoietic disorders and other therapeutic domains in order to advance CRISPR-based therapies. Neurodegenerative diseases, ophthalmological diseases, and multisystem, muscle, and metabolic disorders are included in this category.

September 2023: Former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research (NIBR) Dr. Mark Fishman cofounded Aditum Bio in 2019. Today, the firm announced the formation of Celexor Bio, a portfolio company dedicated to the development of innovative therapies for inflammatory disorders. The in-licensing of a depleting antibody that targets immunoglobulin-like transcript 7 (ILT7), a highly specific cell surface marker present on plasmacytoid dendritic cells (pDCs), is facilitating the formation of Celexor Bio. The closure of the in-licensing is expected to occur later this month. The compound (IMG-018) will be renamed CLXR-901 pending licensing from Inmagene Biopharmaceuticals.

List of Cell Surface Markers Key companies in the market

Bio-Rad Laboratories Ltd.

Abbot

Siemens Healthcare Private Limited

Beckman Coulter Inc.

Hoffman-La Roche Ltd

Nihon Kohden Corporation

Thermo Fisher Scientific

BD Biosciences

Abcam PLC

Qiagen

Danaher

Genscript

Merk KGaA

Biolegend

Cell Signalling Technology Inc.

Cell Surface Markers Market Highlights:

Cell Surface Markers Market Size

Cell Surface Markers Market Trends

Cell Surface Markers Market Analysis

Cell Surface Markers Market Share

Cell Surface Markers Market Highlights:

Cell Surface Markers Market Trends

Cell Surface Markers Market Analysis

Cell Surface Markers Market Share

Cell Surface Markers Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.